Moreover, patients that respond well to programmed cell death protein 1/programmed cell death protein ligand 1 blockade have persistent tumor immune circulating activity in vivo, indicating that CD8 + T cells in HCC tumor tissues can be replenished by infiltrating peripheral CD8 + T cells. The gene discussed is CD8A; the disease is neoplasm.